Valuation: Eckert & Ziegler SE

Market Cap 870M 1B 813M 743M 1.4B 95.83B 1.42B 9.53B 3.74B 47.94B 3.77B 3.69B 160B P/E 2026 *
16.7x
P/E 2027 * 15.8x
Enterprise Value 754M 871M 704M 644M 1.21B 83.04B 1.23B 8.26B 3.24B 41.54B 3.27B 3.2B 138B EV / Sales 2026 *
2.37x
EV / Sales 2027 * 2.19x
Free-Float
67.36%
Yield 2026 *
1.4%
Yield 2027 * 1.44%
1 day+2.56%
Current month+2.56%
1 month-4.67%
1 month 12.29
Extreme 12.293
13.79
Current year 12.29
Extreme 12.293
14.67
1 year 12.29
Extreme 12.293
14.67
3 years 12.29
Extreme 12.293
14.67
5 years 12.29
Extreme 12.293
14.67
10 years 12.29
Extreme 12.293
14.67
Manager TitleAgeSince
Chief Executive Officer 59 07/06/2023
Chief Tech/Sci/R&D Officer - 01/01/2025
Chief Operating Officer 59 01/01/2025
Director TitleAgeSince
Chairman 57 07/06/2023
Director/Board Member 66 01/01/2014
Director/Board Member 58 01/01/2017
Change 5-day change 1-year change 3-year change Capi.($)
+2.56%0.00% - - 1B
-0.08%+4.61%+29.72%-33.93% 17.28B
+5.67%-5.02%-6.81%+102.62% 1.66B
+0.32%+1.98%-27.00%+24.38% 1B
-1.02%-23.07%-42.79%-82.64% 943M
+0.03%+49.35%+89.10%-11.35% 778M
-0.79%+1.52%-37.18%-51.37% 682M
+5.71%+10.00%-43.74%-46.29% 563M
+0.75%+6.08%-44.38%-43.24% 412M
+2.10%+4.17%-6.17%-21.32% 383M
Average +1.51%+49.72%-9.92%-18.13% 2.63B
Weighted average by Cap. +0.56%+173.01%+18.28%-23.84%

Financials

2026 *2027 *
Net sales 319M 368M 298M 272M 513M 35.11B 521M 3.49B 1.37B 17.56B 1.38B 1.35B 58.49B 340M 393M 318M 291M 548M 37.51B 557M 3.73B 1.46B 18.77B 1.48B 1.44B 62.5B
Net income 51.68M 59.7M 48.31M 44.15M 83.19M 5.69B 84.5M 566M 222M 2.85B 224M 219M 9.49B 53.08M 61.32M 49.62M 45.35M 85.46M 5.85B 86.79M 582M 228M 2.93B 230M 225M 9.74B
Net Debt -116M -134M -109M -99.18M -187M -12.79B -190M -1.27B -499M -6.4B -504M -493M -21.31B -126M -145M -117M -107M -202M -13.83B -205M -1.38B -540M -6.92B -544M -532M -23.04B
Logo Eckert & Ziegler SE
Eckert & Ziegler SE is a Germany-based Company, which is a provider of isotope technology for medical, scientific and industrial use with focus on cancer therapy, industrial radiometry and nuclear-medical imaging. The Company operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.
Employees
1,100
Date Price Change
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
13.90EUR
Average target price
21.60EUR
Spread / Average Target
+55.40%

Quarterly revenue - Rate of surprise